HuGE Literature Finder
Records 1-7
|
Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration.
Acta ophthalmologica 2017 Sep . Cobos Estefania, Recalde Sergio, Anter Jaouad, Hernandez-Sanchez Maria, Barreales Carla, Olavarrieta Leticia, Valverde Alicia, Suarez-Figueroa Marta, Cruz Fernando, Abraldes Maximino, Pérez-Pérez Julian, Fernández-Robredo Patricia, Arias Luis, García-Layana Alfre |
|
Evaluation of sFLT1 protein levels in human eyes with the FLT1 rs9943922 polymorphism.
Ophthalmic genetics 2017 Sep 1-5. Chirco Kathleen R, Lewis Carly J, Scheetz Todd E, Johnston Rebecca M, Tucker Budd A, Stone Edwin M, Fingert John H, Mullins Robert |
|
Evaluating VEGFR1 genetic polymorphisms as a predisposition to AMD in a cohort from northern China.
Ophthalmic genetics 2016 Dec 37 (4): 388-393. Xiang Wei, Zhuang Wenjuan, Chi Hao, Sheng Xunlun, Zhang Wen, Xue Zhongqi, Pan Bo, Liu Ya |
|
Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema.
Investigative ophthalmology & visual science 2015 Feb 56 (2): 1122-8. Noma Hidetaka, Mimura Tatsuya, Yasuda Kanako, Shimura Masahi |
|
FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression.
Investigative ophthalmology & visual science 2014 Jun 55 (6): 3543-54. Owen Leah A, Morrison Margaux A, Ahn Jeeyun, Woo Se Joon, Sato Hajime, Robinson Rosann, Morgan Denise J, Zacharaki Fani, Simeonova Marina, Uehara Hironori, Chakravarthy Usha, Hogg Ruth E, Ambati Balamurali K, Kotoula Maria, Baehr Wolfgang, Haider Neena B, Silvestri Giuliana, Miller Joan W, Tsironi Evangelia E, Farrer Lindsay A, Kim Ivana K, Park Kyu Hyung, DeAngelis Margaret |
|
Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
Ophthalmology 2014 Apr 121 (4): 905-10. Hermann Manuel M, van Asten Freekje, Muether Philipp S, Smailhodzic Dzenita, Lichtner Peter, Hoyng Carel B, Kirchhof Bernd, Grefkes Christian, den Hollander Anneke I, Fauser Sasc |
|
The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).
Transactions of the American Ophthalmological Society 2011 Dec 109 115-56. Francis Peter Jam |
- Page last reviewed:Mar 16, 2019
- Page last updated:Apr 02, 2020
- Content source: